Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study82

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study42

Views

Views
April 20253
May 20254
June 20254
July 20259
August 20251
September 202520
October 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States23
Brazil12
Hong Kong3
United Kingdom2
Spain1
Mexico1
 

Top cities views

Views
Dallas16
Hong Kong3
Alegrete1
Brasília1
Cachoeira do Sul1
Canoas1
Charlotte1
Council Bluffs1
Dahlonega1
Duque de Caxias1